Safety Study of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase to Treat Pompe Disease

This study has been completed.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT00976352
First received: July 13, 2009
Last updated: December 8, 2015
Last verified: December 2015